abugarciamassbeat3| WuXi AppTec (603259.SH) plans to subscribe for a share of a U.S. private equity fund mainly invested in innovative biotechnology companies

Zhitong Finance APP Newsabugarciamassbeat3, WuXi AppTec (603259)(603259abugarciamassbeat3.SH) announced that WuXi PharmaTech Healthcare Fund I L.P., a wholly owned subsidiary of the company. ("WuXi Fund I") intends to subscribe for Longwood Special Situations Fund, L.P. ("Investment Fund") Investment fund shares of US$5 million, accounting for approximately 4.52% of the investment fund shares raised. Investment funds are expected to raise a total of no more than US$250 million.

It is reported that the investment fund is a limited partnership established under the laws of the State of Delaware in the United States. It mainly focuses on investing in innovative biotechnology companies in drugs, treatments and related fields. This investment fund is a special opportunity fund initiated by Dr. Christoph Westphal's team. It aims to capture scarce value investment opportunities that arise during the low period of investment and financing in the biotechnology industry, and provide high-potential growth biotechnology companies that have demonstrated excellent preclinical data or clinical data. Provide professional financial support.